JP2023543262A5 - - Google Patents
Info
- Publication number
- JP2023543262A5 JP2023543262A5 JP2023519180A JP2023519180A JP2023543262A5 JP 2023543262 A5 JP2023543262 A5 JP 2023543262A5 JP 2023519180 A JP2023519180 A JP 2023519180A JP 2023519180 A JP2023519180 A JP 2023519180A JP 2023543262 A5 JP2023543262 A5 JP 2023543262A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- polypeptide
- substitution
- canid
- constant domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063084241P | 2020-09-28 | 2020-09-28 | |
| US63/084,241 | 2020-09-28 | ||
| PCT/US2021/052338 WO2022067233A2 (en) | 2020-09-28 | 2021-09-28 | Canine antibody variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543262A JP2023543262A (ja) | 2023-10-13 |
| JP2023543262A5 true JP2023543262A5 (OSRAM) | 2024-09-27 |
Family
ID=78599123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519180A Pending JP2023543262A (ja) | 2020-09-28 | 2021-09-28 | イヌ科動物抗体バリアント |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12612454B2 (OSRAM) |
| EP (1) | EP4217384A2 (OSRAM) |
| JP (1) | JP2023543262A (OSRAM) |
| KR (1) | KR20230079148A (OSRAM) |
| CN (1) | CN116438196A (OSRAM) |
| AR (1) | AR123636A1 (OSRAM) |
| AU (1) | AU2021349301A1 (OSRAM) |
| BR (1) | BR112023005393A2 (OSRAM) |
| CA (1) | CA3194936A1 (OSRAM) |
| CL (2) | CL2023000878A1 (OSRAM) |
| CO (1) | CO2023004102A2 (OSRAM) |
| EC (1) | ECSP23030271A (OSRAM) |
| IL (1) | IL301413A (OSRAM) |
| MX (1) | MX2023003624A (OSRAM) |
| PE (1) | PE20231374A1 (OSRAM) |
| TW (1) | TW202229337A (OSRAM) |
| WO (1) | WO2022067233A2 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022020944A2 (pt) * | 2020-04-17 | 2022-12-27 | Zoetis Services Llc | Variantes de anticorpos caninos |
| EP4217384A2 (en) | 2020-09-28 | 2023-08-02 | Zoetis Services LLC | Canine antibody variants |
| JP2025524441A (ja) * | 2022-06-21 | 2025-07-30 | ゾエティス・サービシーズ・エルエルシー | イヌ科動物抗体変異体 |
| EP4652197A1 (en) | 2023-01-20 | 2025-11-26 | Petmedix Ltd. | Therapeutic antibodies |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| WO2006031370A2 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| BRPI0517837A (pt) | 2004-11-12 | 2008-10-21 | Xencor Inc | variantes fc com ligação alterada a fcrn |
| WO2012024650A2 (en) | 2010-08-19 | 2012-02-23 | Abbott Laboratories | Anti-ngf antibodies and their use |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| JP6629069B2 (ja) | 2012-06-06 | 2020-01-15 | ゾエティス・エルエルシー | イヌ化抗ｎｇｆ抗体およびその方法 |
| EP4124624A3 (en) | 2013-12-20 | 2023-05-03 | Intervet International B.V. | Antibodies against canine pd-1 |
| US20210388053A1 (en) * | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| JP2022513653A (ja) * | 2018-11-28 | 2022-02-09 | ブリストル－マイヤーズ スクイブ カンパニー | 修飾された重鎖定常領域を含む抗体 |
| CN113227134A (zh) * | 2018-12-05 | 2021-08-06 | 株式会社梅花治疗 | 抗体的Fc区变体 |
| SG11202106478UA (en) | 2019-01-03 | 2021-07-29 | Invetx Inc | Compositions for increasing half-life of a therapeutic agent in canines and methods of use |
| BR112022020944A2 (pt) * | 2020-04-17 | 2022-12-27 | Zoetis Services Llc | Variantes de anticorpos caninos |
| US20220119513A1 (en) | 2020-06-08 | 2022-04-21 | Zoetis Services Llc | Anti-tgfb antibodies and therapeutic uses thereof |
| EP4217384A2 (en) | 2020-09-28 | 2023-08-02 | Zoetis Services LLC | Canine antibody variants |
-
2021
- 2021-09-28 EP EP21806440.0A patent/EP4217384A2/en active Pending
- 2021-09-28 MX MX2023003624A patent/MX2023003624A/es unknown
- 2021-09-28 TW TW110136032A patent/TW202229337A/zh unknown
- 2021-09-28 BR BR112023005393A patent/BR112023005393A2/pt unknown
- 2021-09-28 IL IL301413A patent/IL301413A/en unknown
- 2021-09-28 AU AU2021349301A patent/AU2021349301A1/en active Pending
- 2021-09-28 PE PE2023001231A patent/PE20231374A1/es unknown
- 2021-09-28 AR ARP210102697A patent/AR123636A1/es unknown
- 2021-09-28 KR KR1020237014355A patent/KR20230079148A/ko active Pending
- 2021-09-28 CA CA3194936A patent/CA3194936A1/en active Pending
- 2021-09-28 CN CN202180065886.6A patent/CN116438196A/zh active Pending
- 2021-09-28 JP JP2023519180A patent/JP2023543262A/ja active Pending
- 2021-09-28 WO PCT/US2021/052338 patent/WO2022067233A2/en not_active Ceased
- 2021-09-28 US US18/246,716 patent/US12612454B2/en active Active
-
2023
- 2023-03-27 CL CL2023000878A patent/CL2023000878A1/es unknown
- 2023-03-29 CO CONC2023/0004102A patent/CO2023004102A2/es unknown
- 2023-04-25 EC ECSENADI202330271A patent/ECSP23030271A/es unknown
-
2024
- 2024-02-29 CL CL2024000628A patent/CL2024000628A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522029A5 (OSRAM) | ||
| JP2023522030A5 (OSRAM) | ||
| JP2021007390A5 (OSRAM) | ||
| JP2020506898A5 (OSRAM) | ||
| JP2022513025A5 (OSRAM) | ||
| JP2020519643A5 (OSRAM) | ||
| Utani et al. | Laminin chain assembly. Specific sequences at the C terminus of the long arm are required for the formation of specific double-and triple-stranded coiled-coil structures. | |
| JP2023504914A5 (OSRAM) | ||
| JP2020515518A5 (OSRAM) | ||
| JP2022502371A5 (OSRAM) | ||
| JP2006524039A5 (OSRAM) | ||
| JP2022511390A5 (OSRAM) | ||
| CN118063619A (zh) | 工程化的异源二聚体蛋白质 | |
| JP2011514149A5 (OSRAM) | ||
| JPWO2020209318A5 (OSRAM) | ||
| JP2021533779A5 (OSRAM) | ||
| JP2020532285A5 (OSRAM) | ||
| JP2007500744A5 (OSRAM) | ||
| JP2022009816A5 (OSRAM) | ||
| JP2017113019A5 (OSRAM) | ||
| JP2021521781A5 (OSRAM) | ||
| JP2012502969A5 (OSRAM) | ||
| JP2024524534A5 (OSRAM) | ||
| JP2022513653A5 (OSRAM) | ||
| JP2024505072A5 (OSRAM) |